Info
Ownership

Christopher Yea - Insider Trading & Ownership

Location: One Kendall Square, Building 200, Suite 2203, Cambridge, MA
Summary: The estimated net worth of Christopher Yea is at least $1.51M dollars as of May 27, 2025. Christopher Yea is the CHIEF DEVELOPMENT OFFICER of KalVista Pharmaceuticals, Inc. and owns shares of KalVista Pharmaceuticals, Inc. (KALV) stock worth about $1.51M.
Signature: /s/ Benjamin L. Palleiko, Attorney-in-Fact
All Insider Reports: All Insider Reports

Ownership of Christopher Yea

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
KALV	KalVista Pharmaceuticals, Inc.	Chief Development Officer	$1.51M	-$320K	-17.5%	May 22, 2025

Showing 1 to 1 of 1 entries

Insider Transactions Reported by Christopher Yea:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.